Biological Evaluation Services

Meet Biocompatibility Standards with ISO 10993 Compliance

Ensuring the safety and biocompatibility of your medical devices is a critical step in the regulatory process. The biological evaluation of your device’s materials confirms they won’t cause harm when in contact with the human body, a non-negotiable requirement for patient safety and market access.

At Russell Regulatory Consultants, our biological evaluation of medical devices services are designed to manage the challenges of regulatory compliance. We provide expert guidance and support to ensure your products meet all necessary safety standards and are fully compliant with ISO 10993.

Our Biological Evaluation Services

We provide a comprehensive, structured approach to biocompatibility evaluation, from initial planning to final report submission. Our services are tailored to meet the specific needs of your device and its intended use.

Biological Evaluation Plan (BEP) Development

We’ll help you create a robust plan that defines the scope of your biocompatibility evaluation, identifies potential risks, and outlines the necessary testing strategy. Our proactive approach saves time and money by ensuring you conduct the right tests from the outset.

Material and Risk Assessment

We conduct thorough assessments of your device’s materials and their biological risks. That includes an in-depth review of existing data, material composition, and potential degradation products to support a comprehensive biocompatibility of medical devices report.

ISO 10993 Testing Strategy

We provide strategic guidance on selecting the appropriate tests from the ISO 10993 series, such as cytotoxicity, sensitisation, or hemocompatibility. We ensure your testing strategy is compliant with international standards and aligns with regulatory expectations.

Toxicological Risk Assessment

Our experts perform detailed toxicological risk assessments of your device’s constituents, helping to quantify and avoid potential risks to a safe level. This is a key part of your 10993 biocompatibility documentation.

Validation Support

We provide guidance and support for the validation of your biological evaluation process. This ensures that all testing and assessment methodologies are robust, scientifically sound, and capable of withstanding regulatory scrutiny.

Biological Evaluation Report (BER) Compilation

We compile all data, test results, and expert assessments into a clear, concise Biological Evaluation Report. This final document is a key component of your technical file and provides the necessary evidence for regulatory submissions.

Why Biocompatibility Evaluation Is Essential

The biocompatibility of medical devices is a fundamental aspect of product safety. A thorough biocompatibility evaluation process protects patients from adverse reactions, ensures your product is trustworthy, and reduces the likelihood of costly post-market issues or recalls. Following the ISO 10993 standards demonstrates a commitment to safety that regulators, healthcare professionals, and patients can have confidence in.

hospital-doctor-using-spreadsheet-billing-codes

Why Choose Russell Regulatory?

Our team turns the complex requirements of ISO 10993 into a clear, actionable plan. We provide the expertise you need to ensure your medical devices are safe, compliant, and ready for market entry.

ISO 10993 Expertise

Our specialists have extensive knowledge of the ISO 10993 biological evaluation of medical devices standards and their application across different regulatory jurisdictions.

Risk-Based Approach

We integrate the principles of ISO 10993 with a proactive, risk-based strategy to create an evaluation process that is both efficient and defensible.

Comprehensive Documentation

We produce detailed, audit-ready documentation, including the Biological Evaluation Plan and Report, to support your regulatory submissions.

Strategic Support

We work as your partner from concept to market, providing continuous guidance and support throughout the biocompatibility evaluation process.

people having training

Who Benefits from Our Service?

Our biocompatibility of medical devices services are designed for manufacturers and developers of all sizes, from start-ups to established enterprises. Anyone who needs to confidently prove that their medical device is safe for human contact can benefit from our expertise.

FAQs about ISO 10993 and Biological Evaluation

Understanding the requirements for biological evaluation and ISO 10993 can be complex. Here are the answers to some of the most common questions we receive about biocompatibility evaluation and our services.

ISO 10993 biological evaluation of medical devices is a family of international standards that outlines the process for assessing a medical device’s potential biological risks. It provides a framework to ensure that the device is safe for human contact.

Biocompatibility evaluation is assessing a medical device’s materials to determine if they are compatible with a biological system. It involves a series of tests and assessments to ensure the device does not cause toxic, irritating, or allergic reactions.

All medical devices that come into direct or indirect contact with the body must undergo a biocompatibility evaluation. The specific tests required from the ISO 10993 series will depend on the nature and duration of that contact.

ISO 10993 is the standard for the biological evaluation of devices, while ISO 14971 is the standard for general risk management. The two are closely related, with ISO 14971 providing the overarching risk management process that guides which ISO 10993 tests are needed.

Stay Informed with Our Latest Insights

Contact Us

We would love to hear from you and discuss how our regulatory affairs specialists can support your regulatory compliance needs.

Name(Required)